Table 2. Univariable and multivariable analyses of 437 patients with resected IIIA NSCLC.
Variable | RFS | OS | |||||||
---|---|---|---|---|---|---|---|---|---|
Univariable analysis, P | Multivariable analysis | Univariable analysis, P | Multivariable analysis | ||||||
Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P | ||||
Post radiotherapy (yes/no) | <0.001 | 1.499 | 1.122–2.002 | 0.006 | 0.506 | NA | |||
Molecular targeted therapy (yes/no) | <0.001 | 1.895 | 1.413–2.542 | <0.001 | 0.884 | ||||
Tumor size (continued) | 0.001 | 1.114 | 1.061–1.168 | <0.001 | <0.001 | 1.167 | 1.104–1.233 | <0.001 | |
N1p (continued) | <0.001 | 1.068 | 1.028–1.110 | 0.001 | <0.001 | NA | |||
N2p (continued) | <0.001 | 1.046 | 1.023–1.069 | <0.001 | <0.001 | 1.064 | 1.042–1.087 | <0.001 |
NSCLC, non-small cell lung cancer; RFS, recurrence-free survival; OS, overall survival; N1p, count of positive lymph nodes in N1 group; N2p, count of positive lymph nodes in N2 group.